Jim Cramer Just Named Five Stocks He Wants to Buy. The AI Angle on Each One Is Striking

Jim Cramer Just Named Five Stocks

At some point during the third year of a major market theme, the most astute voices in the room begin to subtly alter their opinions. Jim Cramer might have struck gold at that precise moment. The boisterous, frequently divisive, and sometimes extremely correct host of Mad Money recently listed five stocks he hopes to own as 2026 progresses.

Casual observers of the AI trade might not anticipate this list. A pure-play chip company does not exist. No REIT for data centers. There isn’t a startup that promises to upend everything. It turns out that Cramer desires something older, more stable, and a little unexpected.

CategoryDetails
Full NameJames J. Cramer
BornFebruary 10, 1955, Wyndmoor, Pennsylvania
EducationHarvard College (B.A.); Harvard Law School (J.D.)
Notable RoleHost of CNBC’s Mad Money (since 2005)
Previous CareerHedge Fund Manager, Cramer Berkowitz — avg. annual return of 24% over 14 years
Co-FoundedTheStreet.com (1996)
Coined TermFANG (Facebook, Amazon, Netflix, Google)
Current PlatformCNBC Investing Club
Known ForHigh-energy stock picks, rapid-fire market commentary
2026 StrategyPivot from AI builders to AI users — blue chips deploying AI for cost savings

Procter & Gamble, Caterpillar, Johnson & Johnson, American Express, and Boeing The Motley Fool are among his top non-tech AI selections; these companies wouldn’t seem out of place in a pension fund from the 1990s.

What’s remarkable, though, is that each and every one of them has a real AI angle, which is typically different from what you would learn from reading a press release. This type is operational. Silent. driven by cost. Unglamorous in the best sense of the word.

Jim Cramer Just Named Five Stocks
Jim Cramer Just Named Five Stocks

For example, Procter & Gamble is utilizing Nvidia’s technology to lower supply chain costs (CNBC), and Cramer has stated that the full benefits of this endeavor are not yet apparent. One of the most dull consumer staple companies in the world is sitting on an AI efficiency story that Wall Street hasn’t fully priced in, which is almost counterintuitive.

Perhaps that’s precisely why Cramer finds it intriguing. If the upside materializes, it will be a true surprise because the hype cycle has already moved on.

Meanwhile, Johnson & Johnson has come under fire for using AI to develop cancer treatments. The Motley Fool is an app that feels significantly different from the narrative surrounding chatbots and cloud computing that predominated in 2023 and 2024.

Machine learning-driven drug discovery is more difficult, slower, and less visually appealing than a demo reel, but when it succeeds, the results are typically long-lasting. According to Cramer, J&J is one of those companies where technology is doing more than just being discussed during earnings calls.

Cramer’s larger argument is that businesses using AI for operational leverage present a more compelling investment case, and that The Motley Fool’s days of making market-beating gains from common chip or data center stocks are rapidly fading. From a man who created the acronym FANG and spent years encouraging viewers to upgrade to Nvidia, that is a significant change.

The Nasdaq has been declining more than the overall market in 2026, and only two of the Magnificent Seven exceeded the S&P 500’s gains in 2025, according to CNBC. These figures seem to support at least some of his caution.

It’s difficult to ignore how the language surrounding these five choices deviates from the standard Cramer energy. “Buy buy buy” isn’t being said with the typical theatrical urgency. He specifically stated that Procter’s AI-driven gains are “not evident yet,” according to CNBC—a statement that carries an unusual amount of patience for someone who is renowned for his lightning-fast speed.

He also keeps an eye on Goldman Sachs, which is framed not by AI tools but rather by the fact that its trading desks were designed for volatile markets and that a wave of IPOs and M&A activity appears to be emerging CNBC, with AI-related dealmaking lurking beneath it all.

Rather than chasing the parabolic moves, Cramer has defined his investment philosophy as “wise speculation”—taking measured risks on companies with real earnings, clear leadership, and an established place in whatever comes next on TheStreet.

The underlying reasoning here is worth considering, regardless of whether you adhere to Cramer’s strict beliefs or view him as a helpful contrarian signal. The trade in AI is still ongoing. It is merely in motion. Whether investors follow it or continue to focus on the names that have already run is the question.